Astrazeneca Pharma India Ltd Results

Astrazeneca Pharma India Ltd’s revenue jumped 37.9% since last year same period to ₹618.18Cr in the Q3 2025-2026. On a quarterly growth basis, Astrazeneca Pharma India Ltd has generated 9.36% jump in its revenue since last 3-months.

Astrazeneca Pharma India Ltd’s net profit jumped 5.64% since last year same period to ₹32.59Cr in the Q3 2025-2026. On a quarterly growth basis, Astrazeneca Pharma India Ltd has generated -39.89% fall in its net profits since last 3-months.

Astrazeneca Pharma India Ltd’s net profit margin fell -23.4% since last year same period to 5.27% in the Q3 2025-2026. On a quarterly growth basis, Astrazeneca Pharma India Ltd has generated -45.04% fall in its net profit margins since last 3-months.